Literature DB >> 29120751

Breast Cancer: Multiple Subtypes within a Tumor?

Syn Kok Yeo1, Jun-Lin Guan2.   

Abstract

Breast cancer is a heterogeneous disease, and stratification of tumors is paramount to achieve better clinical outcomes. While it is common to stratify and treat breast tumors as a single entity, insights from studies on intratumoral heterogeneity and cancer stem cells raise the possibility that multiple breast cancer subtypes may coexist within a tumor. A role for plasticity in driving dynamic conversions between breast cancer subtypes is proposed, and the clinical implications include a need for combinatorial therapeutic strategies that account for the discrete disease entities and their plasticity. Accordingly, the advent of single-cell technologies will be crucial in enabling the diagnosis and stratification of distinct disease subtypes down to the cellular level.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  breast cancer; cancer stem cells; intratumoral heterogeneity; plasticity

Mesh:

Substances:

Year:  2017        PMID: 29120751      PMCID: PMC5802368          DOI: 10.1016/j.trecan.2017.09.001

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  67 in total

Review 1.  Single-cell epigenomics: techniques and emerging applications.

Authors:  Omer Schwartzman; Amos Tanay
Journal:  Nat Rev Genet       Date:  2015-10-13       Impact factor: 53.242

2.  Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells.

Authors:  Wai Leong Tam; Haihui Lu; Joyce Buikhuisen; Boon Seng Soh; Elgene Lim; Ferenc Reinhardt; Zhenhua Jeremy Wu; Jordan A Krall; Brian Bierie; Wenjun Guo; Xi Chen; Xiaole Shirley Liu; Myles Brown; Bing Lim; Robert A Weinberg
Journal:  Cancer Cell       Date:  2013-09-09       Impact factor: 31.743

3.  Identification of quiescent and spatially restricted mammary stem cells that are hormone responsive.

Authors:  Nai Yang Fu; Anne C Rios; Bhupinder Pal; Charity W Law; Paul Jamieson; Ruijie Liu; François Vaillant; Felicity Jackling; Kevin He Liu; Gordon K Smyth; Geoffrey J Lindeman; Matthew E Ritchie; Jane E Visvader
Journal:  Nat Cell Biol       Date:  2017-02-13       Impact factor: 28.824

4.  Developmental stage-specific contribution of LGR5(+) cells to basal and luminal epithelial lineages in the postnatal mammary gland.

Authors:  Karin E de Visser; Metamia Ciampricotti; Ewa M Michalak; David Wei-Min Tan; Ewoud N Speksnijder; Cheei-Sing Hau; Hans Clevers; Nick Barker; Jos Jonkers
Journal:  J Pathol       Date:  2012-11       Impact factor: 7.996

Review 5.  The mammary stem cell hierarchy: a looking glass into heterogeneous breast cancer landscapes.

Authors:  Amulya Sreekumar; Kevin Roarty; Jeffrey M Rosen
Journal:  Endocr Relat Cancer       Date:  2015-07-23       Impact factor: 5.678

6.  HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab.

Authors:  Suthinee Ithimakin; Kathleen C Day; Fayaz Malik; Qin Zen; Scott J Dawsey; Tom F Bersano-Begey; Ahmed A Quraishi; Kathleen Woods Ignatoski; Stephanie Daignault; April Davis; Christopher L Hall; Nallasivam Palanisamy; Amber N Heath; Nader Tawakkol; Tahra K Luther; Shawn G Clouthier; Whitney A Chadwick; Mark L Day; Celina G Kleer; Dafydd G Thomas; Daniel F Hayes; Hasan Korkaya; Max S Wicha
Journal:  Cancer Res       Date:  2013-02-26       Impact factor: 12.701

7.  Subclonal diversification of primary breast cancer revealed by multiregion sequencing.

Authors:  Lucy R Yates; Moritz Gerstung; Stian Knappskog; Christine Desmedt; Gunes Gundem; Peter Van Loo; Turid Aas; Ludmil B Alexandrov; Denis Larsimont; Helen Davies; Yilong Li; Young Seok Ju; Manasa Ramakrishna; Hans Kristian Haugland; Peer Kaare Lilleng; Serena Nik-Zainal; Stuart McLaren; Adam Butler; Sancha Martin; Dominic Glodzik; Andrew Menzies; Keiran Raine; Jonathan Hinton; David Jones; Laura J Mudie; Bing Jiang; Delphine Vincent; April Greene-Colozzi; Pierre-Yves Adnet; Aquila Fatima; Marion Maetens; Michail Ignatiadis; Michael R Stratton; Christos Sotiriou; Andrea L Richardson; Per Eystein Lønning; David C Wedge; Peter J Campbell
Journal:  Nat Med       Date:  2015-06-22       Impact factor: 53.440

8.  Embryonic cells contribute directly to the quiescent stem cell population in the adult mouse mammary gland.

Authors:  Kata Boras-Granic; Pamela Dann; John J Wysolmerski
Journal:  Breast Cancer Res       Date:  2014-12-03       Impact factor: 6.466

9.  Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases.

Authors:  Nolan Priedigkeit; Ryan J Hartmaier; Yijing Chen; Damir Vareslija; Ahmed Basudan; Rebecca J Watters; Roby Thomas; Jose P Leone; Peter C Lucas; Rohit Bhargava; Ronald L Hamilton; Juliann Chmielecki; Shannon L Puhalla; Nancy E Davidson; Steffi Oesterreich; Adam M Brufsky; Leonie Young; Adrian V Lee
Journal:  JAMA Oncol       Date:  2017-05-01       Impact factor: 31.777

Review 10.  Tumor-associated stromal cells as key contributors to the tumor microenvironment.

Authors:  Karen M Bussard; Lysette Mutkus; Kristina Stumpf; Candelaria Gomez-Manzano; Frank C Marini
Journal:  Breast Cancer Res       Date:  2016-08-11       Impact factor: 6.466

View more
  101 in total

1.  HSP47 promotes metastasis of breast cancer by interacting with myosin IIA via the unfolded protein response transducer IRE1α.

Authors:  Akihiro Yoneda; Kenjiro Minomi; Yasuaki Tamura
Journal:  Oncogene       Date:  2020-05-04       Impact factor: 9.867

2.  Spatially multiplexed RNA in situ hybridization to reveal tumor heterogeneity.

Authors:  Lena Voith von Voithenberg; Anna Fomitcheva Khartchenko; Deborah Huber; Peter Schraml; Govind V Kaigala
Journal:  Nucleic Acids Res       Date:  2020-02-20       Impact factor: 16.971

3.  ZNF750 represses breast cancer invasion via epigenetic control of prometastatic genes.

Authors:  Matteo Cassandri; Alessio Butera; Ivano Amelio; Anna Maria Lena; Manuela Montanaro; Alessandro Mauriello; Lucia Anemona; Eleonora Candi; Richard A Knight; Massimiliano Agostini; Gerry Melino
Journal:  Oncogene       Date:  2020-04-20       Impact factor: 9.867

Review 4.  Comprehensive comparison of theranostic nanoparticles in breast cancer.

Authors:  Amin Nikdouz; Nima Namarvari; Ramin Ghasemi Shayan; Arezoo Hosseini
Journal:  Am J Clin Exp Immunol       Date:  2022-02-15

5.  Development and verification of a three-dimensional (3D) breast cancer tumor model composed of circulating tumor cell (CTC) subsets.

Authors:  Muge Anil-Inevi; Pelin Sağlam-Metiner; Evrim Ceren Kabak; Sultan Gulce-Iz
Journal:  Mol Biol Rep       Date:  2019-10-03       Impact factor: 2.316

6.  A novel immune-related prognostic index for predicting breast cancer overall survival.

Authors:  Xiaosi Yu; Juan Guo; Qian Zhou; Wenjie Huang; Chen Xu; Xinghua Long
Journal:  Breast Cancer       Date:  2020-11-04       Impact factor: 4.239

7.  Divergence of Intracellular Trafficking of Sphingosine Kinase 1 and Sphingosine-1-Phosphate Receptor 3 in MCF-7 Breast Cancer Cells and MCF-7-Derived Stem Cell-Enriched Mammospheres.

Authors:  Olga A Sukocheva; Dong Gui Hu; Robyn Meech; Anupam Bishayee
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

8.  Identification of a Novel Transcription Factor Prognostic Index for Breast Cancer.

Authors:  Junhao Liu; Zexuan Liu; Yangying Zhou; Manting Zeng; Sanshui Pan; Huan Liu; Qiong Liu; Hong Zhu
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

Review 9.  Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies.

Authors:  Jun Cao; Mengdi Zhang; Bin Wang; Long Zhang; Meiyu Fang; Fangfang Zhou
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

10.  Neoantigens elicit T cell responses in breast cancer.

Authors:  Takafumi Morisaki; Makoto Kubo; Masayo Umebayashi; Poh Yin Yew; Sachiko Yoshimura; Jae-Hyun Park; Kazuma Kiyotani; Masaya Kai; Mai Yamada; Yoshinao Oda; Yusuke Nakamura; Takashi Morisaki; Masafumi Nakamura
Journal:  Sci Rep       Date:  2021-06-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.